Cargando…

Comparison of proactive and conventional treatment of anastomotic leakage in rectal cancer surgery: a multicentre retrospective cohort series

PURPOSE: Comparative studies on efficacy of treatment strategies for anastomotic leakage (AL) after low anterior resection (LAR) are almost non-existent. This study aimed to compare different proactive and conservative treatment approaches for AL after LAR. METHODS: This retrospective cohort study i...

Descripción completa

Detalles Bibliográficos
Autores principales: Talboom, K., Greijdanus, N. G., Brinkman, N., Blok, R. D., Roodbeen, S. X., Ponsioen, C. Y., Tanis, P. J., Bemelman, W. A., Cunningham, C., de Lacy, F. B., Hompes, Roel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562258/
https://www.ncbi.nlm.nih.gov/pubmed/37212927
http://dx.doi.org/10.1007/s10151-023-02808-z
_version_ 1785118087361593344
author Talboom, K.
Greijdanus, N. G.
Brinkman, N.
Blok, R. D.
Roodbeen, S. X.
Ponsioen, C. Y.
Tanis, P. J.
Bemelman, W. A.
Cunningham, C.
de Lacy, F. B.
Hompes, Roel
author_facet Talboom, K.
Greijdanus, N. G.
Brinkman, N.
Blok, R. D.
Roodbeen, S. X.
Ponsioen, C. Y.
Tanis, P. J.
Bemelman, W. A.
Cunningham, C.
de Lacy, F. B.
Hompes, Roel
author_sort Talboom, K.
collection PubMed
description PURPOSE: Comparative studies on efficacy of treatment strategies for anastomotic leakage (AL) after low anterior resection (LAR) are almost non-existent. This study aimed to compare different proactive and conservative treatment approaches for AL after LAR. METHODS: This retrospective cohort study included all patients with AL after LAR in three university hospitals. Different treatment approaches were compared, including a pairwise comparison of conventional treatment and endoscopic vacuum-assisted surgical closure (EVASC). Primary outcomes were healed and functional anastomosis rates at end of follow-up. RESULTS: Overall, 103 patients were included, of which 59 underwent conventional treatment and 23 EVASC. Median number of reinterventions was 1 after conventional treatment, compared to 7 after EVASC (p < 0.01). Median follow-up was 39 and 25 months, respectively. Healed anastomosis rate was 61% after conventional treatment, compared to 78% after EVASC (p = 0.139). Functional anastomosis rate was higher after EVASC, compared to conventional treatment (78% vs. 54%, p = 0.045). Early initiation of EVASC in the first week after primary surgery resulted in better functional anastomosis rate compared to later initiation (100% vs. 55%, p = 0.008). CONCLUSION: Proactive treatment of AL consisting of EVASC resulted in improved healed and functional anastomosis rates for AL after LAR for rectal cancer, compared to conventional treatment. If EVASC was initiated within the first week after index surgery, a 100% functional anastomosis rate was achievable. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10151-023-02808-z.
format Online
Article
Text
id pubmed-10562258
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-105622582023-10-11 Comparison of proactive and conventional treatment of anastomotic leakage in rectal cancer surgery: a multicentre retrospective cohort series Talboom, K. Greijdanus, N. G. Brinkman, N. Blok, R. D. Roodbeen, S. X. Ponsioen, C. Y. Tanis, P. J. Bemelman, W. A. Cunningham, C. de Lacy, F. B. Hompes, Roel Tech Coloproctol Original Article PURPOSE: Comparative studies on efficacy of treatment strategies for anastomotic leakage (AL) after low anterior resection (LAR) are almost non-existent. This study aimed to compare different proactive and conservative treatment approaches for AL after LAR. METHODS: This retrospective cohort study included all patients with AL after LAR in three university hospitals. Different treatment approaches were compared, including a pairwise comparison of conventional treatment and endoscopic vacuum-assisted surgical closure (EVASC). Primary outcomes were healed and functional anastomosis rates at end of follow-up. RESULTS: Overall, 103 patients were included, of which 59 underwent conventional treatment and 23 EVASC. Median number of reinterventions was 1 after conventional treatment, compared to 7 after EVASC (p < 0.01). Median follow-up was 39 and 25 months, respectively. Healed anastomosis rate was 61% after conventional treatment, compared to 78% after EVASC (p = 0.139). Functional anastomosis rate was higher after EVASC, compared to conventional treatment (78% vs. 54%, p = 0.045). Early initiation of EVASC in the first week after primary surgery resulted in better functional anastomosis rate compared to later initiation (100% vs. 55%, p = 0.008). CONCLUSION: Proactive treatment of AL consisting of EVASC resulted in improved healed and functional anastomosis rates for AL after LAR for rectal cancer, compared to conventional treatment. If EVASC was initiated within the first week after index surgery, a 100% functional anastomosis rate was achievable. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10151-023-02808-z. Springer International Publishing 2023-05-22 2023 /pmc/articles/PMC10562258/ /pubmed/37212927 http://dx.doi.org/10.1007/s10151-023-02808-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Talboom, K.
Greijdanus, N. G.
Brinkman, N.
Blok, R. D.
Roodbeen, S. X.
Ponsioen, C. Y.
Tanis, P. J.
Bemelman, W. A.
Cunningham, C.
de Lacy, F. B.
Hompes, Roel
Comparison of proactive and conventional treatment of anastomotic leakage in rectal cancer surgery: a multicentre retrospective cohort series
title Comparison of proactive and conventional treatment of anastomotic leakage in rectal cancer surgery: a multicentre retrospective cohort series
title_full Comparison of proactive and conventional treatment of anastomotic leakage in rectal cancer surgery: a multicentre retrospective cohort series
title_fullStr Comparison of proactive and conventional treatment of anastomotic leakage in rectal cancer surgery: a multicentre retrospective cohort series
title_full_unstemmed Comparison of proactive and conventional treatment of anastomotic leakage in rectal cancer surgery: a multicentre retrospective cohort series
title_short Comparison of proactive and conventional treatment of anastomotic leakage in rectal cancer surgery: a multicentre retrospective cohort series
title_sort comparison of proactive and conventional treatment of anastomotic leakage in rectal cancer surgery: a multicentre retrospective cohort series
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562258/
https://www.ncbi.nlm.nih.gov/pubmed/37212927
http://dx.doi.org/10.1007/s10151-023-02808-z
work_keys_str_mv AT talboomk comparisonofproactiveandconventionaltreatmentofanastomoticleakageinrectalcancersurgeryamulticentreretrospectivecohortseries
AT greijdanusng comparisonofproactiveandconventionaltreatmentofanastomoticleakageinrectalcancersurgeryamulticentreretrospectivecohortseries
AT brinkmann comparisonofproactiveandconventionaltreatmentofanastomoticleakageinrectalcancersurgeryamulticentreretrospectivecohortseries
AT blokrd comparisonofproactiveandconventionaltreatmentofanastomoticleakageinrectalcancersurgeryamulticentreretrospectivecohortseries
AT roodbeensx comparisonofproactiveandconventionaltreatmentofanastomoticleakageinrectalcancersurgeryamulticentreretrospectivecohortseries
AT ponsioency comparisonofproactiveandconventionaltreatmentofanastomoticleakageinrectalcancersurgeryamulticentreretrospectivecohortseries
AT tanispj comparisonofproactiveandconventionaltreatmentofanastomoticleakageinrectalcancersurgeryamulticentreretrospectivecohortseries
AT bemelmanwa comparisonofproactiveandconventionaltreatmentofanastomoticleakageinrectalcancersurgeryamulticentreretrospectivecohortseries
AT cunninghamc comparisonofproactiveandconventionaltreatmentofanastomoticleakageinrectalcancersurgeryamulticentreretrospectivecohortseries
AT delacyfb comparisonofproactiveandconventionaltreatmentofanastomoticleakageinrectalcancersurgeryamulticentreretrospectivecohortseries
AT hompesroel comparisonofproactiveandconventionaltreatmentofanastomoticleakageinrectalcancersurgeryamulticentreretrospectivecohortseries